Shenzhen BGI Acquires California Based Human Genomic Sequencing Company
One of the leading international genomics organizations BGI has completed its acquisition of Complete Genomics, a company based in California that specializes in human genomic sequencing. The company BGI is based in Shenzhen.
BGI successfully accomplished the acquisition by cash tender that was offered to purchase all of Complete Genomics outstanding share of common stock for around US$3.15 a share. This was followed by a short term merger that took effect on Monday. The CEO of BGI Dr. Wang Jun said that they are happy with the acquisition of Complete and now that they have merged into one company. He also said that they value the employees and the work that the company have already achieve and its contributions will be help BGI research on the complete and accurate whole human genome sequencing technology.
The company is now looking forward in working to support and the advancement of innovative biological technology and health care. Both companies shared a vision on how whole genome sequencing will revolutionize clinical medicine. By merging the two companies will allow them to focus further on high volume and accurate human genomic sequencing while accelerating the spread of genomic medicine